106 related articles for article (PubMed ID: 7831450)
1. Long-term treatment of depression with nefazodone.
Anton SF; Robinson DS; Roberts DL; Kensler TT; English PA; Archibald DG
Psychopharmacol Bull; 1994; 30(2):165-9. PubMed ID: 7831450
[TBL] [Abstract][Full Text] [Related]
2. Efficacy in long-term treatment of depression.
Montgomery SA
J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
[TBL] [Abstract][Full Text] [Related]
3. Nefazodone: aspects of efficacy.
Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL
J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973
[TBL] [Abstract][Full Text] [Related]
4. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
[TBL] [Abstract][Full Text] [Related]
5. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
[TBL] [Abstract][Full Text] [Related]
6. Redefining antidepressant efficacy toward long-term recovery.
Thase ME
J Clin Psychiatry; 1999; 60 Suppl 6():15-9. PubMed ID: 10235120
[TBL] [Abstract][Full Text] [Related]
7. A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression.
Feighner JP; Pambakian R; Fowler RC; Boyer WF; D'Amico MF
Psychopharmacol Bull; 1989; 25(2):219-21. PubMed ID: 2690165
[TBL] [Abstract][Full Text] [Related]
8. Nefazodone and imipramine in major depression: a placebo-controlled trial.
Rickels K; Schweizer E; Clary C; Fox I; Weise C
Br J Psychiatry; 1994 Jun; 164(6):802-5. PubMed ID: 7952987
[TBL] [Abstract][Full Text] [Related]
9. Nefazodone in the treatment of severe, melancholic, and recurrent depression.
Marcus RN; Mendels J
J Clin Psychiatry; 1996; 57 Suppl 2():19-23. PubMed ID: 8626359
[TBL] [Abstract][Full Text] [Related]
10. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
Zajecka JM
J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
[TBL] [Abstract][Full Text] [Related]
11. Tolerability and safety: essentials in antidepressant pharmacotherapy.
Lader MH
J Clin Psychiatry; 1996; 57 Suppl 2():39-44. PubMed ID: 8626362
[TBL] [Abstract][Full Text] [Related]
12. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
[TBL] [Abstract][Full Text] [Related]
13. The short- and long-term efficacy of paroxetine HCl: B. Data from a double-blind crossover study and from a year-long term trial vs. imipramine and placebo.
Peselow ED; Filippi AM; Goodnick P; Barouche F; Fieve RR
Psychopharmacol Bull; 1989; 25(2):272-6. PubMed ID: 2532374
[No Abstract] [Full Text] [Related]
14. The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo.
Peselow ED; Filippi AM; Goodnick P; Barouche F; Fieve RR
Psychopharmacol Bull; 1989; 25(2):267-71. PubMed ID: 2532373
[No Abstract] [Full Text] [Related]
15. A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
Fontaine R; Ontiveros A; Elie R; Kensler TT; Roberts DL; Kaplita S; Ecker JA; Faludi G
J Clin Psychiatry; 1994 Jun; 55(6):234-41. PubMed ID: 8071277
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic dose range of nefazodone in the treatment of major depression.
Robinson DS; Marcus RN; Archibald DG; Hardy SA
J Clin Psychiatry; 1996; 57 Suppl 2():6-9. PubMed ID: 8626365
[TBL] [Abstract][Full Text] [Related]
17. The safety profile of nefazodone.
Robinson DS; Roberts DL; Smith JM; Stringfellow JC; Kaplita SB; Seminara JA; Marcus RN
J Clin Psychiatry; 1996; 57 Suppl 2():31-8. PubMed ID: 8626361
[TBL] [Abstract][Full Text] [Related]
18. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
Schweizer E; Feighner J; Mandos LA; Rickels K
J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
[TBL] [Abstract][Full Text] [Related]
19. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
[TBL] [Abstract][Full Text] [Related]
20. Depression: a long-term illness and its treatment.
Montgomery SA; Kasper S
Int Clin Psychopharmacol; 1998 Jul; 13 Suppl 6():S23-6. PubMed ID: 9728671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]